ArticleEJNMMI radiopharmacy and chemistry2021
Automated synthesis of [
Article in EJNMMI radiopharmacy and chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Sugar Amino Acid Linkers for the Design of [ChemMedChem · 2026Article
- Impact of different PSMA PET-based eligibility criteria on outcome of [EJNMMI research · 2026Article
- Automated Synthesis of Radiopharmaceuticals: Technology, Applications, and Regulatory Perspectives.Nuclear medicine and molecular imaging · 2026Review
- Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026Review
- Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Radiopharmaceuticals and their applications in medicine.Signal transduction and targeted therapy · 2025Review
- FDA-approved drugs featuring macrocycles or medium-sized rings.Archiv der Pharmazie · 2025Review
- Optimization and scale up of production of the PSMA imaging agent [EJNMMI radiopharmacy and chemistry · 2024Article
- Good practices for the automated production ofEJNMMI radiopharmacy and chemistry · 2023Article
- Validation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination onJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends.Frontiers in nuclear medicine · 2022Article
- Radiolabeled PSMA Inhibitors.Cancers · 2021Review
- Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA)Pharmaceuticals (Basel, Switzerland) · 2021Review
- Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage RadiotherapyFrontiers in oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionThe radiohybrid (rh) prostate-specific membrane antigen (PSMA)-targeted ligand [
methods[
resultsThe automated production of [
conclusionThis investigation demonstrates that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.